Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats

Simple item page
dc.contributor.authorRamadas, M
dc.contributor.authorPaul, W
dc.contributor.authorDileep, KJ
dc.contributor.authorAnitha, Y
dc.contributor.authorSharma, CP
dc.date.accessioned2017-03-10T03:27:26Z
dc.date.available2017-03-10T03:27:26Z
dc.date.issued2000
dc.description.abstractAn oral formulation based on liposome encapsulated alginate-chitosan gel capsules was developed for insulin delivery for the treatment of diabetes. Liposome encapsulation helped to increase the encapsulation efficiency of insulin in alginate-chitosan capsules. This formulation delivers insulin in the neutral environment of the intestine, by-passing the acidic media in the stomach, with increased drug absorption and bioavailability. Oral administration of this formulation was found to reduce blood glucose levels when tested in diabetic rats.
dc.identifier.citation17 ,4;405-411en_US
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/10002
dc.publisherJOURNAL OF MICROENCAPSULATION
dc.subjectChemistry; Engineering; Pharmacology & Pharmacy
dc.titleLipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats
Files
Collections
Journal Articles